According to SEC filings for the period ending December 2025, BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is held by 10 institutional firms.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 1,028,053 | 1,028,053 | 0.00% | $2,631,816.00 |
| OAKTREE CAPITAL MANAGEMENT LP | 30 Sep, 2025 | 241,188 | 0 | 0.00% | $617,443.00 |
| FMR LLC | 30 Sep, 2025 | 198,600 | 198,600 | 0.00% | $508,416.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 192,125 | 173,301 | 920.64% | $491,840.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 125,240 | 97,058 | 344.40% | $320,622.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 84,282 | 66,504 | 374.08% | $215,762.00 |
| STATE STREET CORP | 30 Sep, 2025 | 52,718 | 52,718 | 0.00% | $134,958.00 |
| UBS Group AG | 30 Sep, 2025 | 43,542 | 3,660 | 9.18% | $111,468.00 |
| Oaktree Fund Advisors, LLC | 30 Sep, 2025 | 42,913 | 0 | 0.00% | $109,857.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 37,733 | 37,733 | 0.00% | $96,597.00 |
| JONES FINANCIAL COMPANIES LLLP | 30 Sep, 2025 | 36,000 | 10,000 | 38.46% | $97,200.00 |
| HighTower Advisors, LLC | 30 Sep, 2025 | 35,000 | 10,400 | 42.28% | $89,600.00 |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 30 Sep, 2025 | 29,549 | 29,549 | 0.00% | $75,645.00 |
| SLT Holdings LLC | 30 Sep, 2025 | 29,500 | 29,500 | 0.00% | $75,520.00 |
| WELLS FARGO & COMPANY/MN | 30 Sep, 2025 | 16,316 | -603 | -3.56% | $41,769.00 |
| OSAIC HOLDINGS, INC. | 30 Sep, 2025 | 15,083 | 10,030 | 198.50% | $61,066.00 |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 30 Sep, 2025 | 15,000 | 0 | 0.00% | $28,500.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 6,881 | 5,334 | 344.80% | $17,615.00 |
| IFP Advisors, Inc | 30 Sep, 2025 | 4,370 | 4,370 | 0.00% | $11,187.00 |
| Tower Research Capital LLC (TRC) | 30 Sep, 2025 | 3,933 | 2,563 | 187.08% | $10,068.00 |